Triangle Venture Day draws investment pros to hear 20 ‘Tech & Med’ startup pitches

RESEARCH TRIANGLE PARK – The strength of the Triangle took on special meaning on Thursday as the region’s three major research universities joined forces with the North Carolina Biotechnology Center to stage a “shopping spree” for some 50+ life sciences investors.

The University of North Carolina at Chapel Hill, Duke University and North Carolina State University were front-and-center with representatives of 20 life sciences spinouts, each providing 15-minute pitches to the audience of investors gathered at NCBiotech for the inaugural version of “Triangle Venture Day: Emerging Tech & Med.”

“This was an important opportunity for us to share exciting examples of our leading life sciences ecosystem in a collaborative and efficient forum,” said Vivian Doelling, Ph.D., vice president for investments and emerging company development at NCBiotech. The event included NC-based life sciences investors, plus out-of-state groups.

These 20 ‘Tech & Med’ startups make their pitches at Triangle Venture Day

Following brief introductions by Jeff Welch, director of Duke New Ventures, more than 100 entrepreneurs and venture fund representatives dove into possibilities for commercializing a wide range of potential therapies and technologies that are in process across the Triangle.

Besides Duke New Ventures, UNC KickStart Ventures and the NCSU Office of Research Commercialization, the roster included investment professionals and other specialists from Innovate Carolina, KdT Ventures, Plains Ventures, Rex Health Ventures, Cone Health Ventures, WakeMed, Tech Coast Angels – San Diego, Novant Health, Pulvinar Neuro, Hatteras Venture Partners, Alexandria Venture Investments, Anzu Partners, Excelerate Health Ventures, Duke Angel Network, Triangle Angel Partners, Hockey Stick Investments, Mitsui & Co. Global Investments, Bluedoor, Wolfpack Investor Network, First Health, RTP Capital Associates, Moore Capital, NC Biolabs, The Launch Place, Eshelman Institute for Innovation, IDEA Fund Partners, Ideal Medical Tech, CVS Health Ventures, Tethis, Echo Health Ventures and RedHill Biopharma.

Here are the company reps who lined up to make presentations, and brief notes about their significance.

Leave a Reply

Your email address will not be published. Required fields are marked *